Stocksigma LogoStocksigma Logo

Pharmaids Pharmaceuticals Reports Q2 FY27 Consolidated Results with Reduced Net Loss

Pharmaids Pharmaceuticals reported consolidated revenue from operations of Rs 433.56 lakh for the quarter ended 30th Sep'26, down 49.6% YoY from Rs 860.50

Pharmaids Pharmaceuticals Reports Q2 FY27 Consolidated Results with Reduced Net Loss

Pharmaids Pharmaceuticals Ltd 路 Financial Result 路 12 Nov 2026, 12:58 am

Pharmaids Pharmaceuticals Reports Q2 FY27 Consolidated Results with Reduced Net Loss Pharmaids Pharmaceuticals reported consolidated revenue from operations of Rs 433.56 lakh for the quarter ended 30th Sep'26, down 49.6% YoY from Rs 860.50 lakh, but up 5.2% QoQ from Rs 412.14 lakh. Consolidated net loss narrowed to Rs 180.91 lakh compared to a loss of Rs 322.94 lakh in the year-ago period. For H1 FY27, revenue stood at Rs 845.69 lakh versus Rs 1,526.86 lakh in H1 FY26, while the company turned profitable with a net profit of Rs 6.24 lakh compared to a net loss of Rs 780.61 lakh YoY.

Original exchange filing (PDF)

More announcements from Pharmaids Pharmaceuticals Ltd

All Pharmaids Pharmaceuticals Ltd announcements